WILLOW LTE Trademark

Trademark Overview

On Tuesday, September 6, 2022, a trademark application was filed for WILLOW LTE with the United States Patent and Trademark Office. The USPTO has given the WILLOW LTE trademark a serial number of 79351320. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, March 11, 2025. This trademark is owned by Merck KGaA. The WILLOW LTE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Clinical research in the field of autoimmune disease
willow lte

General Information

Serial Number79351320
Word MarkWILLOW LTE
Filing DateTuesday, September 6, 2022
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, March 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 11, 2025

Trademark Statements

NOT AVAILABLE"LTE"
Goods and ServicesClinical research in the field of autoimmune disease

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 30, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMerck KGaA
Party Type20 - Owner at Publication
Legal Entity Type31 - NOT AVAILABLE
AddressDE
Party NameMerck KGaA
Party Type10 - Original Applicant
Legal Entity Type31 - NOT AVAILABLE
AddressDE

Trademark Events

Event DateEvent Description
Thursday, February 23, 2023NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Thursday, September 29, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, September 30, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 4, 2022APPLICATION FILING RECEIPT MAILED
Friday, February 10, 2023ASSIGNED TO EXAMINER
Wednesday, February 22, 2023NON-FINAL ACTION WRITTEN
Thursday, February 23, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, March 1, 2023NON-FINAL ACTION WRITTEN
Thursday, March 2, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, April 24, 2023REFUSAL PROCESSED BY MPU
Tuesday, April 25, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, May 17, 2023REFUSAL PROCESSED BY IB
Thursday, October 19, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 19, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 19, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 2, 2023SUSPENSION LETTER WRITTEN
Thursday, November 2, 2023LETTER OF SUSPENSION E-MAILED
Thursday, November 2, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, March 6, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, June 12, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, January 17, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 17, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 6, 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Monday, March 25, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Friday, May 3, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, January 17, 2025TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, February 4, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, February 4, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, February 18, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 5, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 11, 2025PUBLISHED FOR OPPOSITION
Tuesday, March 11, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Related Keywords

willow disease autoimmune field research clinical